Padovani A, Benussi A, Cotelli MS, et al. - Researchers assessed the clinical value of transcranial magnetic stimulation (TMS) on diagnostic confidence and confidence in mild cognitive impairment (MCI) patients relative to amyloid markers, taking into account the experience of clinicians. Participants in the study included 104 patients with MCI. Overall, TMS had a significant impact on diagnostic reliability and confidence in addition to routine clinical evaluation in patients with MCI, comparable to well-established amyloidosis biomarkers.